Skip to main content
Premium Trial:

Request an Annual Quote

Strata Biosciences Wins Research Grant From NCI

Premium

ALAMEDA, Calif.--Strata Biosciences here was awarded a $100,000 Small Business Innovation Research grant from the US National Cancer Institute for a six-month functional genomics technology innovation project. Strata is a privately funded functional genomics company implementing proprietary high-throughput gene knockout technologies for gene discovery, drug target identification, and validation.

According to Douglas Lane, president and chief executive officer, Strata's technology has the capacity to validate and target genes at a rate exceeding industry standards. "These proprietary tools accelerate the most critical step of conventional pharmaceutical innovation, resulting in cost-effective drug discovery," he said.

Combining molecular biology, high-throughput screening, bioinformatics, and cell-based models, Strata's efforts are focused on research in the areas of prostate, breast, and ovarian cancer, and immune regulation.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.